Is Lexicon Pharmaceuticals, Inc. (LXRX) a Buy, Sell, or Hold?
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$2.115 USD
-$0.01 (-0.24%)
- Volume
- 28.23K
- Average Volume
- 3.22M
- Market Capitalization
- $939.47M
- P/E Ratio
- -29.62
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $2.68
- Year Low
- $1.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.79
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
123
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
61
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 4.5M
LXRX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
LXRX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Swain Judith L | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Swain Judith L | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Sullivan Diane E. | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Sullivan Diane E. | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| SOBECKI CHRISTOPHER J | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| SOBECKI CHRISTOPHER J | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Cheung Ivan | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Cheung Ivan | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| BARKER SAM L | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| BARKER SAM L | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Amouyal Philippe | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Amouyal Philippe | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| DEBBANE RAYMOND | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| DEBBANE RAYMOND | director | 2026-06-03 | M-Exempt | 0 | 2026-06-04 |
| Artal Participations S.a r.l. | director, 10 percent owner: | 2026-04-30 | M-Exempt | 0 | 2026-05-08 |
| Artal Participations S.a r.l. | director, 10 percent owner: | 2026-04-30 | A-Award | 0 | 2026-05-08 |
| Artal Participations S.a r.l. | director, 10 percent owner: | 2026-04-30 | M-Exempt | 0 | 2026-05-08 |
| Amouyal Philippe | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| Amouyal Philippe | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| SOBECKI CHRISTOPHER J | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| SOBECKI CHRISTOPHER J | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| BARKER SAM L | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| BARKER SAM L | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| Cheung Ivan | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| Cheung Ivan | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| Swain Judith L | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| Swain Judith L | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| Sullivan Diane E. | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| Sullivan Diane E. | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| DEBBANE RAYMOND | director | 2026-05-01 | A-Award | 1.61 | 2026-05-04 |
| DEBBANE RAYMOND | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Martens Rachel Yap | officer: SVP, Partnerships & Corp Strat | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Martens Rachel Yap | officer: SVP, Partnerships & Corp Strat | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Martens Rachel Yap | officer: SVP, Partnerships & Corp Strat | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Coiante Scott M | officer: SVP, Chief Financial Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Coiante Scott M | officer: SVP, Chief Financial Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Coiante Scott M | officer: SVP, Chief Financial Officer | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| Exton Michael | director, officer: Chief Executive Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Exton Michael | director, officer: Chief Executive Officer | 2026-02-28 | M-Exempt | 0 | 2026-03-03 |
| Exton Michael | director, officer: Chief Executive Officer | 2026-02-28 | F-InKind | 1.47 | 2026-03-03 |
| DEBBANE RAYMOND | director | 2026-02-25 | P-Purchase | 1.49 | 2026-02-27 |
| DEBBANE RAYMOND | director | 2026-02-23 | P-Purchase | 1.47 | 2026-02-25 |
| DEBBANE RAYMOND | director | 2026-02-20 | P-Purchase | 1.4779 | 2026-02-23 |
| DEBBANE RAYMOND | director | 2026-02-19 | P-Purchase | 1.4393 | 2026-02-23 |
| Artal Participations S.a r.l. | director, 10 percent owner: | 2026-02-17 | A-Award | 65 | 2026-02-19 |
| DEBBANE RAYMOND | director | 2026-02-18 | P-Purchase | 1.32 | 2026-02-18 |
| DEBBANE RAYMOND | director | 2026-02-17 | P-Purchase | 1.3082 | 2026-02-18 |
| DEBBANE RAYMOND | director | 2026-02-13 | P-Purchase | 1.3093 | 2026-02-18 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| McDermott Wendy | officer: SVP, Human Resources | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Martens Rachel Yap | officer: SVP, Partnerships & Corp Strat | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| Martens Rachel Yap | officer: SVP, Partnerships & Corp Strat | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| Granowitz Craig B | officer: SVP, Chief Medical Officer | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| Gopinathan Suma | officer: SVP, Discovery | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| DeFrancesco Lisa | officer: SVP, IR and Corp Comm | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| Crum Brian T | officer: SVP, General Counsel & Secr. | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Coiante Scott M | officer: SVP, Chief Financial Officer | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| Coiante Scott M | officer: SVP, Chief Financial Officer | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Exton Michael | director, officer: Chief Executive Officer | 2026-02-12 | A-Award | 1.37 | 2026-02-17 |
| Exton Michael | director, officer: Chief Executive Officer | 2026-02-12 | A-Award | 0 | 2026-02-17 |
| Avicenna Life Sci Master Fund LP | director, 10 percent owner: | 2026-02-02 | 0 | 2026-02-12 | |
| Invus Global Management, LLC | director, 10 percent owner: | 2026-02-02 | A-Award | 1.3 | 2026-02-04 |
| Invus Global Management, LLC | director, 10 percent owner: | 2026-02-02 | A-Award | 1.3 | 2026-02-04 |